Information Provided By: 
Fly News Breaks for January 31, 2018
SNGX
Jan 31, 2018 | 07:05 EDT
H.C. Wainwright Joseph Pantginis downgraded Soligenix to Neutral and lowered his price target for the shares to $2.70 from $5.50. The analyst cites the continued pushing out of timelines for the company's clinical programs as the rationale for the downgrade. He believes clear visibility is needed to drive the investment case.
News For SNGX From the Last 2 Days
